Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael B Fallon

Showing results (171-180 of 174) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 174 results.
Metabolism: Clinical and Experimental|June 28, 2024
Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease study 2019Pojsakorn Danpanichkul, Kanokphong Suparan, Priyata Dutta, et al.
United European Gastroenterology Journal|July 3, 2025
The Rising Global Burden of MASLD and Other Metabolic Diseases (2000-2021)Pojsakorn Danpanichkul, Kanokphong Suparan, Luis Antonio Diaz, et al.
Hepatology (Baltimore, Md.)|May 15, 2020
Estrogen Signaling and Portopulmonary Hypertension: The Pulmonary Vascular Complications of Liver Disease Study (PVCLD2)Nadine Al-Naamani, Michael J Krowka, Kimberly A Forde, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 18, 2021
North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal HypertensionJustin R Boike, Bartley G Thornburg, Sumeet K Asrani, et al.
Pageof 18

Showing results (171-180 of 174) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 174 results.
Metabolism: Clinical and Experimental|June 28, 2024
Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease study 2019Pojsakorn Danpanichkul, Kanokphong Suparan, Priyata Dutta, et al.
United European Gastroenterology Journal|July 3, 2025
The Rising Global Burden of MASLD and Other Metabolic Diseases (2000-2021)Pojsakorn Danpanichkul, Kanokphong Suparan, Luis Antonio Diaz, et al.
Hepatology (Baltimore, Md.)|May 15, 2020
Estrogen Signaling and Portopulmonary Hypertension: The Pulmonary Vascular Complications of Liver Disease Study (PVCLD2)Nadine Al-Naamani, Michael J Krowka, Kimberly A Forde, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 18, 2021
North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal HypertensionJustin R Boike, Bartley G Thornburg, Sumeet K Asrani, et al.
Pageof 18